Symptom-triggered testing shows promise for identifying early-stage ovarian cancer

Researchers evaluate the efficacy of symptom-triggered testing in detecting early-stage ovarian cancer.

U.S. News & World Report Integrates 3M AM-PPCs with Best Hospitals Specialty Rankings

by Jasmine Pennic 07/14/2023 Leave a Comment What You Should Know: U.S. News & World Report will incorporate the 3M™ Ambulatory Potentially Preventable Complications (3M

July 15, 2023

Study identifies genes increasing risk of severe COVID-19

Whether or not a person becomes seriously ill with COVID-19 depends, among other things, on genetic factors. With this in mind, researchers from the University

July 25, 2024

MD Anderson and Rigel partner to expand olutasidenib evaluation in AML and other cancers

The University of Texas MD Anderson Cancer Center and Rigel Pharmaceuticals, Inc. today announced a multi-year strategic development collaboration to expand the evaluation of olutasidenib

December 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.